2003
Synta Pharma founded and MIA granted
Synta started as a small business in Overton Hampshire with the purchase of just three Marketing Authorisations in 2003. Synta obtained MHRA GMP approval for their Pharmaceutical Management System and commenced distribution from their internal GDP warehouses on site in Overton.
2014
Southern Depot Purchased in Andover
Synta’s portfolio had substantially increased by 2014 and the company required additional storage. In 2014 Synta purchased the first of their distribution sites in Andover, Hampshire. At 75,000ft2 with increased pallet capacity it provided the opportunity for Synta to increase their product range and stock holdings.
2016
Northern Depot Purchased in Barnsley
In 2016 Synta purchased their second distribution site in Barnsley, South Yorkshire. At over 82,000ft2 with double the pallet capacity of Andover Barnsley added increased opportunity for Synta to pursue larger contracts and continue rapid growth in product range.
2016
London Manufacturing Site Purchased
Additional to the purchase of a further distribution centre Synta added a manufacturing plant and warehouse in London to the portfolio. Additional storage was essential for Brexit stock builds and the advantage of UK based manufacturing in the capital was a unique opportunity for Synta.
2019
Synta International Malta
Synta International Malta was established in 2019 to safeguard against the impacts of Brexit and to strengthen our interaction the EU marketplace.
2019
Basingstoke Head Office
Synta’s head office moved from the site of establishment in Overton UK to a larger site in Basingstoke UK. The new site houses office space for 100+ employees whilst still maintaining a small number of core staff at the original site in Overton.
2022
Thorpe Laboratories
Synta acquired Thorpe Laboratories an MHRA approved specials, liquid, gels and semi solids manufacturing site based in Mablethorpe UK.
2022
Synta Medical UK
Synta purchased the solid dosage manufacturing site previously occupied by M&A Pharmachem based in Bolton UK.
2023
Synta R&D
Acquisition of Archimedis Healthcare Limited, a leading Pharmaceutical Research and development facility basing in Chennai, India, into the Synta group.
Synta R&D has MHRA approved manufacturing capability for solid dosage form as well extensive laboratory expertise for the continued development of our portfolio.